What is the latest status of the project “Lilly Huntsville Manufacturing Facility”?

The status recorded for “Lilly Huntsville Manufacturing Facility” is planned.

What is the budget and commercial profile for the project “Lilly Huntsville Manufacturing Facility”?

Taiyo normalizes the budget of “Lilly Huntsville Manufacturing Facility” to USD 6000000000.

Where can I verify the source and access all details for “Lilly Huntsville Manufacturing Facility”?

This Taiyo project page references C&EN along with the original URL (https://cen.acs.org/business/Dec-16-Business-Watch-Polymer/103/web/2025/12). Taiyo standardizes official data into a consistent, searchable project profile.

Lilly Huntsville Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Huntsville, Alabama, United States

Source: C&EN

Project

Planned

Eli Lilly and Company plans to build a new manufacturing facility for peptides and small molecules in Huntsville, Alabama. The facility will produce orforglipron, a small molecule drug candidate for obesity, and is expected to create 450 new jobs. Construction will start in 2026 and complete by 2032.

Status: Prospective
Sector: Manufacturing (Industrial)
Location: Huntsville, Alabama, United States of America
Updated: 22 Jul 2026
Source: C&EN

ConstructChat

Ask ConstructChat about Lilly Huntsville Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “Lilly Huntsville Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Huntsville, Alabama, United States. Taiyo aggregates data on it from C&EN.

Participants

Not available for this record.

Status

Original status	planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Eli Lilly and Company plans to build a new manufacturing facility for peptides and small molecules in Huntsville, Alabama. The facility will produce orforglipron, a small molecule drug candidate for obesity, and is expected to create 450 new jobs. Construction will start in 2026 and complete by 2032.
Original sector	Pharmaceuticals
Budget

Location

Country	United States of America (USA)
State	Alabama
City	Huntsville

Source

Source	C&EN
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial)
Article published date	2025-12-19

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

Lilly Huntsville Manufacturing Facility

Ask ConstructChat about Lilly Huntsville Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States